Status: Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
This study is Phase I/IIa First-in-Human Study of \[212Pb\]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Tumors
Participants needed: 300
Trial details
Phase: Phase 1, Phase 2Age: 18-90Biological sex: AllType: InterventionalSponsor: Perspective TherapeuticsUpdated: May 14, 2026Locations: 19
Eligibility criteria
Adult (ages ≥18) PRRT-naïve subjects with NETs or meningioma by local pathology. [+16]
Known hypersensitivity to SSA, SSTR imaging agents or any of the excipients of [... [+19]